Presentation details results from Biosense Webster's global, multicenter STELLAR study IRVINE, Calif., Feb. 3, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia ...
Please provide your email address to receive an email when new articles are posted on . Compared with a sham procedure, pulmonary vein isolation reduced atrial fibrillation burden at 6 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback